U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197086) titled 'Clinical and Treatment Determinant of Prognosis in Glioblastoma' on Sept. 21.
Brief Summary: Gliomas represent the most common primary malignant brain tumors in adults, with glioblastoma (WHO grade 4) being the most aggressive subtype. Despite advances in surgical techniques, radiotherapy, and chemotherapy, prognosis remains poor, particularly for high-grade gliomas. Maximal safe surgical resection is considered a cornerstone in the management of gliomas. Several studies suggest that a greater extent of resection (EOR) is associated with improved overall survival (OS) and progression-free survival (PFS), particularly in high-grade ...